0001209191-23-053030.txt : 20231017
0001209191-23-053030.hdr.sgml : 20231017
20231017195753
ACCESSION NUMBER: 0001209191-23-053030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230725
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peraza Lisa
CENTRAL INDEX KEY: 0001828266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 231330700
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-25
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001828266
Peraza Lisa
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
VP, Chief Accounting Officer
0
Common Stock
2023-07-25
4
M
0
42631
A
67941
D
Common Stock
2023-07-25
4
F
0
14743
1.51
D
53198
D
Common Stock
2023-10-13
4
M
0
552
A
53750
D
Common Stock
2023-10-13
4
M
0
1932
A
55682
D
Common Stock
2023-10-13
4
F
0
860
0.72
D
54822
D
Performance Stock Units
2023-07-25
4
M
0
42631
0.00
D
Common Stock
42631
0
D
Restricted Stock Units
2023-10-13
4
M
0
552
0.00
D
Common Stock
552
2208
D
Restricted Stock Units
2023-10-13
4
M
0
1932
0.00
D
Common Stock
1932
7964
D
Restricted stock units convert into common stock on a one-for-one basis.
Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs were further subject to a time-based vesting schedule. The PSUs vested in full on the first anniversary of the grant date (July 25, 2023).
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).
/s/ Lisa Peraza
2023-10-17